BDAZ

"I'm impressed. In diabetic, recent ACS patients 70 years or older w/ baseline MoCA <22, apabetalone elicited a statistically significant 158% increase in MoCA vs. placebo in BETonMACE cognition sub-study."

So 158% vs placebo. Perhaps it is obvious but I'm not a scientist. Question I have is did this actually improve MoCA vs baseline? Ie did these brain functions increase or did they not deteriorate as much?

Sorry to ask if the answer is obvious. Thanks

Toinv